Olaposi I. Omotuyi

According to our database, Olaposi I. Omotuyi authored at least 5 papers between 2015 and 2023.

Collaborative distances:

• Dijkstra number of five.
• Erdős number of five.

2023

QSAR-based virtual screening of traditional Chinese medicine for the identification of mitotic kinesin Eg5 inhibitors.

Damilola S. Bodun, Damilola A. Omoboyowa, Olaposi I. Omotuyi, Ezekiel A. Olugbogi, Toheeb A. Balogun, Chiamaka J. Ezeh, Emmanuel S. Omirin

Comput. Biol. Chem., June, 2023

2022

SARS-CoV-2 Omicron spike glycoprotein receptor binding domain exhibits super-binder ability with ACE2 but not convalescent monoclonal antibody.

Olaposi I. Omotuyi, Olujide O. Olubiyi, Oyekanmi Nash, Elizabeth Afolabi, E. Babatunji Oyinloye, Segun A. Fatumo, Mbang Femi-Oyewo, Suleiman Bogoro

Comput. Biol. Medicine, 2022

2020

Atomistic simulation reveals structural mechanisms underlying D614G spike glycoprotein-enhanced fitness in SARS-COV -2.

Olaposi I. Omotuyi, Oyekanmi Nash, O. Basiru Ajiboye, C. Gift Iwegbulam, E. Babatunji Oyinloye, O. Abimbola Oyedeji, Z. Abimbola Kashim, Kunle Okaiyeto

J. Comput. Chem., 2020

Computational and drug target analysis of functional single nucleotide polymorphisms associated with Haemoglobin Subunit Beta (<i>HBB</i>) gene.

Opeyemi S. Soremekun, Chisom Ezenwa, Itunuoluwa Isewon, Mahmoud E. S. Soliman, Olaposi I. Omotuyi, Oyekanmi Nashiru, Segun A. Fatumo

Comput. Biol. Medicine, 2020

2015

Molecular dynamics study-based mechanism of nefiracetam-induced NMDA receptor potentiation.

Olaposi I. Omotuyi, Hiroshi Ueda

Comput. Biol. Chem., 2015